Table 1.
Baseline characteristics of the study population.
| Total (n = 117,053) | Men (n = 54,013) | Women (n = 63,040) | |
|---|---|---|---|
| Age at baseline (years), mean ± SD | 50.1 ± 15.6 | 49.9 ± 15.0 | 50.2 ± 16.1 |
| Age at fracture (years), mean ± SD | 77.0 ± 11.6 | 72.4 ± 14.3 | 78.9 ± 9.7 |
| BMI (kg/m2), median (P20, P40, P60, P80) | 25.2 (21.9, 24.2, 26.2, 29.0) | 25.8 (23, 25, 26.7, 29.1) | 24.3 (21, 23.2, 25.6, 29.0) |
| MAP (mm Hg), median (P20, P40, P60, P80) | 96.7 (86.7, 93.3, 100, 106.7) | 98 (90, 96.6, 100, 100.3) | 95 (85, 93.3, 98.3, 106.7) |
| Blood glucose (mg/dl), median (P20, P40, P60, P80) | 91 (81, 88, 94, 102) | 93 (83, 90, 96, 105) | 89 (80, 86, 92, 100) |
| Triglycerides (mg/dl), median (P20, P40, P60, P80) | 102 (68, 89, 112, 166) | 116 (74, 101, 134, 193) | 92 (62, 82, 105, 145) |
| Cholesterol (mg/dl), median (P20, P40, P60, P80) | 213 (179, 203, 224, 251) | 213 (180, 203, 224, 250) | 213 (178, 202, 224, 252) |
| BMI ≥ 30 (kg/m2), n (%) | 18,023 (15.4) | 7985 (14.8) | 10,038 (15.9) |
| Blood glucose ≥ 126 mg/dl, n (%) | 5691 (4.9) | 3067 (5.7) | 2624 (4.2) |
| Cholesterol ≥ 200 mg/dl, n (%) | 73,554 (62.8) | 34,270 (63.4) | 39,284 (62.3) |
| Triglycerides ≥ 150 mg/dl, n (%) | 29,496 (25.2) | 17,875 (33.1) | 11,621 (18.4) |
| Hypertension, n (%) | 47,810 (40.8) | 24,269 (44.9) | 23,541 (37.3) |
| Smoking status, n (%) | |||
| Non-smoker | 76,711 (65.54) | 30,847 (57.11) | 45,864 (72.75) |
| Ex-smoker | 15,463 (13.21) | 10,030 (18.57) | 5433 (8.62) |
| Smoker | 24,879 (21.25) | 13,136 (24.32) | 11,743 (18.63) |
| Hip fractures, n (%) | 947 (0.81) | 280 (0.52) | 667 (1.06) |
BMI, body mass index; MAP, mean arterial pressure. P percentile. Hypertension: systolic blood pressure ≥140 mm Hg; diastolic blood pressure ≥90 mm Hg.